

Classification: Growth Factor Peptide
Active substance: Insulin-like Growth Factor-1 Long R3
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 1 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous (SC) Injection
Lab Test: View Result
In the highest echelons of bodybuilding and performance enhancement, where marginal gains are fought for with extreme dedication, Dragon Pharma IGF-1 LR3 stands as a pinnacle achievement in peptide science. This is not merely another growth factor; it is a scientifically engineered, long-acting analog of Insulin-like Growth Factor-1, specifically modified to resist binding proteins and dramatically extend its half-life in the body. This LR3 (Long R3) modification translates into a sustained, powerful anabolic signal that promotes true muscle hyperplasia (the creation of new muscle cells), unparalleled nutrient shuttling, and profound recovery. With an independent lab verification confirming 1.05 mg of raw material at 99.96% purity, this product represents the absolute gold standard for athletes demanding verified potency and transformative results.
IGF-1 LR3 operates through multiple powerful mechanisms that directly influence muscle tissue, fat cells, and overall metabolism. Its effects are both systemic and, when applied correctly, locally targeted.
Proper administration is critical to maximizing the benefits of IGF-1 LR3. Dragon Pharma's 1 mg vial offers flexibility for precise dosing.
IGF-1 LR3 is a powerful force multiplier when stacked with other compounds. Its nutrient-shuttling properties can enhance the effects of virtually any cycle.
While highly effective, IGF-1 LR3 requires respect and careful management to avoid potential side effects.
The integrity of this potent peptide is paramount. For maximum stability, reconstitute with acetic acid (0.6% AA) if possible. If using bacteriostatic water, be aware the solution may be less stable long-term. Once reconstituted, the vial must be stored refrigerated (36°-46°F / 2°-8°C) and protected from light. The reconstituted solution is best used within 20-30 days. Never freeze the solution. Practice impeccable sterile technique: use alcohol swabs on the vial stopper and injection site, and use insulin syringes for accurate, low-volume subcutaneous injections.
Date: 2024-01-19
Result: 1.05 mg; Purity: 99.962%
Standard IGF-1 has a very short half-life (minutes) because it quickly binds to proteins in the blood. IGF-1 LR3 is a modified analog where the third amino acid is replaced with arginine and a 13-amino acid extension peptide is added. This modification drastically reduces its binding affinity, giving it a much longer half-life (20-30 hours). This means IGF-1 LR3 provides a sustained, systemic anabolic effect from a single daily injection, whereas standard IGF-1 requires multiple injections for a much shorter burst of activity.
If you feel dizzy, shaky, sweaty, or nauseous after an injection, you are likely experiencing hypoglycemia. Immediately consume a fast-acting carbohydrate source. Keep a sugary drink (like regular soda or fruit juice), glucose tablets, or candy nearby whenever you use IGF-1 LR3. The symptoms should subside within 5-10 minutes after intake. To prevent this, always plan to have a meal containing carbs and protein within 30-60 minutes of your injection.
Cycles typically range from 4 to 8 weeks. A common and effective protocol is 4 weeks on, followed by 4 weeks off. This helps prevent desensitization and mitigates potential long-term risks. Longer cycles (6-8 weeks) can be undertaken by experienced users but should be followed by an equal time off. Continuous use for many months is not recommended due to the theoretical risk of organ enlargement and receptor desensitization.
Extreme caution is advised. IGF-1 LR3 has strong insulin-like effects and can significantly lower blood sugar. If you have pre-existing insulin resistance or diabetes, your ability to regulate blood glucose is already compromised. Using IGF-1 LR3 could lead to dangerous hypoglycemic episodes. It is strongly recommended to consult with a healthcare professional and have a deep understanding of your own body's response before considering use.
No, IGF-1 LR3 does not aromatize (convert to estrogen) and therefore does not directly cause gynecomastia. It is not a hormone in the traditional steroid sense. However, its powerful nutrient-shuttling effects can influence overall growth factors. It is often used in stacks with compounds that do aromatize, so an AI like Dragon Pharma Arimidex may be needed for the other compounds in your cycle, but not for the IGF-1 LR3 itself.
Please log in to write IGF-1 LR3 1 mg review.
Classification: Growth Hormone Secretagogue (GHRP)
Active substance: Ipamorelin
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous (SC) Injection
Lab Test: View Result
Classification: Synthetic Melanocortin Peptide
Active substance: Melanotan II
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder / 10 mg per vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection (Reconstituted with Bacteriostatic Water)
Lab Test: View Result
Classification: Metabolic Peptide (GLP-1/GIP Receptor Agonist)
Active substance: Tirzepatide
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial
Route: Subcutaneous Injection (Reconstitution Required)
Lab Test: View Result
Classification: Nootropic Peptide
Active substance: Semax
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder / 5 mg per 2 mL vial
Pack size: 1 Vial
Route: Intranasal or Subcutaneous
Lab Test: View Result
Classification: Research Peptide (Body Protecting Compound)
Active substance: BPC 157 (Pentadecapeptide)
Manufacturer: Dragon Pharma
Form/Strength: Lyophilized Powder, 5 mg/vial
Pack size: 2 mL Vial (Requires Reconstitution)
Route: Subcutaneous (SubQ) or Near Injury
Lab Test: View Result